Reine Allan 4
4 · Prime Medicine, Inc. · Filed Dec 9, 2024
Insider Transaction Report
Form 4
Reine Allan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-12-05+75,000→ 775,000 totalExercise: $6.80Exp: 2034-01-17→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Represents an option initially granted to the Reporting Person on January 17, 2024, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On December 5, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 75,000 shares.